Suppr超能文献

非酒精性脂肪性肝病中的性别和种族差异。

Gender and racial differences in nonalcoholic fatty liver disease.

作者信息

Pan Jen-Jung, Fallon Michael B

机构信息

Jen-Jung Pan, Michael B Fallon, Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX 77030, United States.

出版信息

World J Hepatol. 2014 May 27;6(5):274-83. doi: 10.4254/wjh.v6.i5.274.

Abstract

Due to the worldwide epidemic of obesity, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of elevated liver enzymes. NAFLD represents a spectrum of liver injury ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) which may progress to advanced fibrosis and cirrhosis. Individuals with NAFLD, especially those with metabolic syndrome, have higher overall mortality, cardiovascular mortality, and liver-related mortality compared with the general population. According to the population-based studies, NAFLD and NASH are more prevalent in males and in Hispanics. Both the gender and racial ethnic differences in NAFLD and NASH are likely attributed to interaction between environmental, behavioral, and genetic factors. Using genome-wide association studies, several genetic variants have been identified to be associated with NAFLD/NASH. However, these variants account for only a small amount of variation in hepatic steatosis among ethnic groups and may serve as modifiers of the natural history of NAFLD. Alternatively, these variants may not be the causative variants but simply markers representing a larger body of genetic variations. In this article, we provide a concise review of the gender and racial differences in the prevalence of NAFLD and NASH in adults. We also discuss the possible mechanisms for these disparities.

摘要

由于全球肥胖流行,非酒精性脂肪性肝病(NAFLD)已成为肝酶升高的最常见原因。NAFLD代表了一系列肝脏损伤,从单纯性脂肪变性到非酒精性脂肪性肝炎(NASH),后者可能进展为晚期纤维化和肝硬化。与普通人群相比,NAFLD患者,尤其是那些患有代谢综合征的患者,总体死亡率、心血管死亡率和肝脏相关死亡率更高。根据基于人群的研究,NAFLD和NASH在男性和西班牙裔中更为普遍。NAFLD和NASH在性别和种族上的差异可能归因于环境、行为和遗传因素之间的相互作用。通过全基因组关联研究,已经确定了几种与NAFLD/NASH相关的基因变异。然而,这些变异在不同种族的肝脂肪变性中仅占一小部分变异,可能作为NAFLD自然史的调节因子。或者,这些变异可能不是致病变异,而仅仅是代表更大遗传变异体的标记。在本文中,我们简要综述了成人NAFLD和NASH患病率的性别和种族差异。我们还讨论了这些差异的可能机制。

相似文献

1
Gender and racial differences in nonalcoholic fatty liver disease.
World J Hepatol. 2014 May 27;6(5):274-83. doi: 10.4254/wjh.v6.i5.274.
2
and polymorphisms in Brazilian patients with nonalcoholic fatty liver disease.
World J Hepatol. 2020 Oct 27;12(10):792-806. doi: 10.4254/wjh.v12.i10.792.
4
Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals.
Am J Physiol Gastrointest Liver Physiol. 2019 Apr 1;316(4):G462-G472. doi: 10.1152/ajpgi.00358.2018. Epub 2019 Jan 17.
6
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
8
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
9
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
World J Gastroenterol. 2019 Mar 21;25(11):1307-1326. doi: 10.3748/wjg.v25.i11.1307.
10
Nonalcoholic fatty liver disease and cardiovascular disease.
Curr Pharm Des. 2014;20(14):2403-11. doi: 10.2174/13816128113199990476.

引用本文的文献

2
Non-alcoholic fatty liver disease among people living with HIV on long-term antiretroviral therapy in Indonesia: Prevalence and related factors.
SAGE Open Med. 2024 Dec 18;12:20503121241292678. doi: 10.1177/20503121241292678. eCollection 2024.
7
Evaluating the burden of illness of metabolic dysfunction-associated steatohepatitis in a large managed care population: The ETHEREAL Study.
J Manag Care Spec Pharm. 2024 Dec;30(12):1414-1430. doi: 10.18553/jmcp.2024.24106. Epub 2024 Sep 27.
9
Trends of primary liver cancer incidence and mortality in the United States: A population-based study over the last four decades.
PLoS One. 2024 Sep 5;19(9):e0309465. doi: 10.1371/journal.pone.0309465. eCollection 2024.
10
Automated Fibrosis-4 Index: Simplifying Non-Alcoholic Fatty Liver Disease for Diabetologists.
Medicina (Kaunas). 2024 Aug 8;60(8):1278. doi: 10.3390/medicina60081278.

本文引用的文献

1
Common genetic variants and nonalcoholic Fatty liver disease.
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1191-3. doi: 10.1016/j.cgh.2013.05.013. Epub 2013 May 21.
4
Racial differences in nonalcoholic fatty liver disease in the U.S. population.
Obesity (Silver Spring). 2014 Jan;22(1):292-9. doi: 10.1002/oby.20426. Epub 2013 Jun 11.
6
Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis.
Science. 2013 Jan 11;339(6116):172-7. doi: 10.1126/science.1230721.
8
Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease.
Dig Dis Sci. 2013 Apr;58(4):1132-40. doi: 10.1007/s10620-012-2446-3. Epub 2012 Nov 10.
9
Nonalcoholic fatty liver disease in lean individuals in the United States.
Medicine (Baltimore). 2012 Nov;91(6):319-327. doi: 10.1097/MD.0b013e3182779d49.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验